Lee et al. showed that EVs isolated from mesenchymal stem cells (MSC) were able to inhibit tumor growth and angiogenesis in a murine model of breast cancer, by downregulating VEGF production in breast cancer cells [98]. This evidence concerns the gene VEGFA and breast cancer.